Cargando…

Healthcare antitrust, settlements, and the Federal Trade Commission /

This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission (""FTC"").

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Langenfeld, James (Editor ), Galeano, Edwin (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Bingley, UK : Emerald Publishing, 2018.
Edición:First edition.
Colección:Research in law and economics (Emerald Publishing (Firm)) ; v. 28.
Temas:
Acceso en línea:Texto completo
Texto completo

MARC

LEADER 00000cam a2200000 i 4500
001 EBOOKCENTRAL_on1049149977
003 OCoLC
005 20240329122006.0
006 m o d
007 cr cnu|||unuuu
008 180821s2018 enk ob 001 0 eng d
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d N$T  |d EBLCP  |d YDX  |d OCLCF  |d NLE  |d MERUC  |d COO  |d UKMGB  |d OCLCQ  |d OTZ  |d CAUOI  |d UKAHL  |d OCLCQ  |d VT2  |d K6U  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCL 
016 7 |a 018893821  |2 Uk 
019 |a 1049603806  |a 1049935205  |a 1170519398  |a 1171039283  |a 1262687076 
020 |a 9781787565999  |q (electronic bk.) 
020 |a 1787565998  |q (electronic bk.) 
020 |a 9781787566019 
020 |a 1787566013 
020 |z 9781787566002 
020 |z 1787566005 
029 1 |a UKMGB  |b 018893821 
035 |a (OCoLC)1049149977  |z (OCoLC)1049603806  |z (OCoLC)1049935205  |z (OCoLC)1170519398  |z (OCoLC)1171039283  |z (OCoLC)1262687076 
037 |a 9781787566019  |b Emerald Publishing 
043 |a n-us--- 
050 4 |a KF3827.A58 
072 7 |a LAW  |x 001000  |2 bisacsh 
072 7 |a KC  |2 bicssc 
080 |a 343 
082 0 4 |a 344.730321  |2 23 
049 |a UAMI 
245 0 0 |a Healthcare antitrust, settlements, and the Federal Trade Commission /  |c edited by James Langenfeld, Edwin Galeano. 
250 |a First edition. 
264 1 |a Bingley, UK :  |b Emerald Publishing,  |c 2018. 
300 |a 1 online resource 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Research in law and economics ;  |v volume 28 
504 |a Includes bibliographical references and index. 
588 |a Online resource; title from PDF title page (EBSCO, viewed August 23, 2018). 
505 0 |a Front Cover; Healthcare Antitrust, Settlements, and the Federal Trade Commission; Copyright Page; Contents; About the Editors; List of Contributors; Acknowledgments; Introduction; "To Know Where You're Going, Look at Where You've Been"; Introduction; Pharmaceuticals: A Case of FTC Investment and Consumption; Provider Mergers: Clear Guidance from Litigated Cases; No Need for Special Rules for Healthcare Markets; ACKNOWLEDGMENT; Notes; References; Actavis, Authorized Generics, and the Future of Antitrust Law; Introduction; Background; Merits Analysis; Hatch-Waxman Background. 
505 8 |a Applying Merits Analysis to Hatch-WaxmanPre-Actavis Analysis of Hatch-Waxman Settlements; Federal Trade Commission v. Actavis; Understanding Actavis; Bribing Generics to Stay Out of the Market; Hypotheticals; H1. The Litigants' Expectations about Litigation are Correct; H2. The Parties Both Believe that the Brand Holds a "Strong" Patent; H3. No Alignment in Expectations; H4. Pessimistic Litigants Split the Patent Life with No Net Reverse Payment; H5a. The Brand Prevailed in a Litigation Challenging Patent Validity but Settles a Second Challenge. 
505 8 |a H5b. The Settlement Fails and the Parties Continue to LitigateH6. No Alignment in Expectations but Risk Aversion Leads to Settlements; H7a. Efficiencies; H7b. Efficiencies; Some Conclusions Derived from the Hypotheticals; Without Legal Limitations, There Will Be Anticompetitive Hatch-Waxman Settlements; Actavis Abandons the Preponderance-of-the-Evidence Standard for Determining Anticompetitive Effects; If the Parties' Expectations Are Correct, Absent Risk Aversion, on Average, Consumers Are Often No Better Off with the Acta ... ; Not Accounting for Risk Profiles May Harm Consumers. 
505 8 |a Actavis Relies on Intent EvidenceActavis Relies on the Intent of the Brand, Not Necessarily the Generic; If the Parties' Expectations Are Not Correct, the Actavis Solution May Make Consumers Worse Off than Merits Analysis; Even in a Settlement without a Net Reverse Payment, One of the Parties May Intend to Achieve an Anticompetitive Effect; Actavis Circumvents Other Elements of Conventional Antitrust Analysis; A Red Flag Is Central to the Actavis Methodology; There Is No Easy Means of Balancing Efficiencies against Anticompetitive Effects Using the Actavis Methodology. 
505 8 |a Additional Unresolved Actavis IssuesAntitrust Injury; Damages; The Slippery Slope of Mt. Actavis; The No-AG Agreement; Applying Actavis to Difficult IP/Antitrust Cases; Antitrust Guidelines for the Licensing of Intellectual Property; Actavis beyond the IP/Antitrust Interface; Where Are We Going?; Notes; Acknowledgment; References; Solving the Product-Hopping Conundrum through Safe Harbors and a No-Economic-Sense Test; Introduction; Product Hopping; Forms of Product Hopping; Hatch-Waxman Act; State Drug Product Selection Laws; Timing of Generic Entry; A New Product-Hopping Framework. 
520 |a This volume of Research in Law and Economics contains articles that address important legal and economic developments in the areas of healthcare, intellectual property and labor settlements, competitive effects, cartel overcharges, and the U.S. Federal Trade Commission (""FTC""). 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
590 |a ProQuest Ebook Central  |b Ebook Central Academic Complete 
590 |a Emerald Insight  |b Emerald All Book Titles 
650 0 |a Antitrust law  |z United States. 
650 0 |a Medical care  |x Law and legislation  |z United States. 
650 7 |a Economics.  |2 bicssc 
650 7 |a LAW  |x Administrative Law & Regulatory Practice.  |2 bisacsh 
650 7 |a Antitrust law  |2 fast 
650 7 |a Medical care  |x Law and legislation  |2 fast 
651 7 |a United States  |2 fast  |1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq 
700 1 |a Langenfeld, James,  |e editor. 
700 1 |a Galeano, Edwin,  |e editor. 
758 |i has work:  |a Healthcare antitrust, settlements, and the Federal Trade Commission (Text)  |1 https://id.oclc.org/worldcat/entity/E39PCGGjbHQqHHDhBTwQ684MKd  |4 https://id.oclc.org/worldcat/ontology/hasWork 
776 0 8 |i Print version:  |t Healthcare antitrust, settlements, and the Federal Trade Commission.  |b First edition.  |d Bingley, UK : Emerald Publishing, 2018  |z 1787566005  |z 9781787566002  |w (OCoLC)1023605369 
830 0 |a Research in law and economics (Emerald Publishing (Firm)) ;  |v v. 28. 
856 4 0 |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=5287270  |z Texto completo 
856 4 0 |u https://www.emerald.com/insight/publication/doi/10.1108/S0193-5895201828  |z Texto completo 
938 |a Askews and Holts Library Services  |b ASKH  |n AH33899879 
938 |a Askews and Holts Library Services  |b ASKH  |n AH33899877 
938 |a EBL - Ebook Library  |b EBLB  |n EBL5287270 
938 |a EBSCOhost  |b EBSC  |n 1708662 
938 |a YBP Library Services  |b YANK  |n 15660743 
994 |a 92  |b IZTAP